SIMILAR PATTERN OF AMINO ACIDS MAPPED TO '5f83'

List of Similar Pattern of Amino Acids

Hit pattern: 3D amino acid arrangements similar to known drug binding site

Query pattern: Residues from known binding site for annotated drug that match the hit pattern


(Click on the DrReposER ID to view details on interfaces and similar patterns of amino acids)
(Click on the view link on the last column to view superposed patterns of amino acids)
Filter list by:
DrReposER ID / Desc. Hit
PDBID
Hit
Macromolecule
Res.
Matches
Interface HETATM RMSD Dali
Z-score
Seq.
Identity (%)
View Dock
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1GHM_A_CEDA1_1
(BETA-LACTAMASE)
5f83 BETA-LACTAMASE
(Pseudomonas
aeruginosa)
7 / 12 SER A  64
LYS A  67
SER A 125
ASN A 127
LYS A 229
GLY A 231
ARG A 238
IM2  A 301 (-1.4A)
IM2  A 301 ( 3.9A)
IM2  A 301 (-2.7A)
IM2  A 301 (-3.2A)
IM2  A 301 (-3.3A)
IM2  A 301 (-3.3A)
IM2  A 301 (-3.5A)
0.29A 1ghmA-5f83A:
35.6
1ghmA-5f83A:
28.83
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1I2W_A_CFXA1300_1
(BETA-LACTAMASE)
5f83 BETA-LACTAMASE
(Pseudomonas
aeruginosa)
8 / 12 SER A  64
LYS A  67
SER A 125
ASN A 127
GLU A 161
THR A 211
LYS A 229
GLY A 231
IM2  A 301 (-1.4A)
IM2  A 301 ( 3.9A)
IM2  A 301 (-2.7A)
IM2  A 301 (-3.2A)
IM2  A 301 (-2.5A)
IM2  A 301 (-4.1A)
IM2  A 301 (-3.3A)
IM2  A 301 (-3.3A)
0.33A 1i2wA-5f83A:
37.7
1i2wA-5f83A:
35.00
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1I2W_B_CFXB2300_1
(BETA-LACTAMASE)
5f83 BETA-LACTAMASE
(Pseudomonas
aeruginosa)
8 / 12 SER A  64
LYS A  67
SER A 125
ASN A 127
GLU A 161
THR A 211
GLY A 231
ARG A 238
IM2  A 301 (-1.4A)
IM2  A 301 ( 3.9A)
IM2  A 301 (-2.7A)
IM2  A 301 (-3.2A)
IM2  A 301 (-2.5A)
IM2  A 301 (-4.1A)
IM2  A 301 (-3.3A)
IM2  A 301 (-3.5A)
0.32A 1i2wB-5f83A:
37.8
1i2wB-5f83A:
35.00
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1PK9_B_2FAB307_1
(PURINE NUCLEOSIDE
PHOSPHORYLASE)
5f83 BETA-LACTAMASE
(Pseudomonas
aeruginosa)
5 / 9 MET A 164
GLY A 128
GLU A 163
SER A 100
ASP A 126
IM2  A 301 ( 4.6A)
None
None
None
None
1.49A 1pk9B-5f83A:
undetectable
1pk9B-5f83A:
23.39
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1PW7_A_RABA645_1
(PURINE NUCLEOSIDE
PHOSPHORYLASE)
5f83 BETA-LACTAMASE
(Pseudomonas
aeruginosa)
5 / 10 MET A 164
GLY A 128
GLU A 163
SER A 100
ASP A 126
IM2  A 301 ( 4.6A)
None
None
None
None
1.49A 1pw7A-5f83A:
undetectable
1pw7A-5f83A:
23.05
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1YMX_A_CFXA1001_1
(BETA-LACTAMASE
CTX-M-9)
5f83 BETA-LACTAMASE
(Pseudomonas
aeruginosa)
8 / 12 SER A  64
LYS A  67
SER A 125
ASN A 127
GLU A 161
THR A 211
LYS A 229
GLY A 231
IM2  A 301 (-1.4A)
IM2  A 301 ( 3.9A)
IM2  A 301 (-2.7A)
IM2  A 301 (-3.2A)
IM2  A 301 (-2.5A)
IM2  A 301 (-4.1A)
IM2  A 301 (-3.3A)
IM2  A 301 (-3.3A)
0.59A 1ymxA-5f83A:
39.6
1ymxA-5f83A:
37.64
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1YMX_A_CFXA1001_1
(BETA-LACTAMASE
CTX-M-9)
5f83 BETA-LACTAMASE
(Pseudomonas
aeruginosa)
8 / 12 SER A  64
LYS A  67
SER A 125
ASN A 127
THR A 211
LYS A 229
GLY A 231
ASP A 166
IM2  A 301 (-1.4A)
IM2  A 301 ( 3.9A)
IM2  A 301 (-2.7A)
IM2  A 301 (-3.2A)
IM2  A 301 (-4.1A)
IM2  A 301 (-3.3A)
IM2  A 301 (-3.3A)
None
1.16A 1ymxA-5f83A:
39.6
1ymxA-5f83A:
37.64
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1YMX_B_CFXB1002_1
(BETA-LACTAMASE
CTX-M-9)
5f83 BETA-LACTAMASE
(Pseudomonas
aeruginosa)
7 / 12 SER A  64
LYS A  67
SER A 125
ASN A 127
GLU A 161
LYS A 229
GLY A 231
IM2  A 301 (-1.4A)
IM2  A 301 ( 3.9A)
IM2  A 301 (-2.7A)
IM2  A 301 (-3.2A)
IM2  A 301 (-2.5A)
IM2  A 301 (-3.3A)
IM2  A 301 (-3.3A)
0.57A 1ymxB-5f83A:
39.4
1ymxB-5f83A:
37.64
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1YMX_B_CFXB1002_1
(BETA-LACTAMASE
CTX-M-9)
5f83 BETA-LACTAMASE
(Pseudomonas
aeruginosa)
6 / 12 SER A  64
LYS A  67
SER A 125
ASN A 127
LYS A 229
ASP A 166
IM2  A 301 (-1.4A)
IM2  A 301 ( 3.9A)
IM2  A 301 (-2.7A)
IM2  A 301 (-3.2A)
IM2  A 301 (-3.3A)
None
0.80A 1ymxB-5f83A:
39.4
1ymxB-5f83A:
37.64
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1YMX_B_CFXB1002_2
(BETA-LACTAMASE
CTX-M-9)
5f83 BETA-LACTAMASE
(Pseudomonas
aeruginosa)
4 / 5 CYH A 233
PRO A 260
THR A 215
THR A 230
None
None
None
IM2  A 301 (-3.6A)
1.42A 1ymxB-5f83A:
39.4
1ymxB-5f83A:
37.64
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2HA4_A_ACTA544_0
(ACETYLCHOLINESTERASE)
5f83 BETA-LACTAMASE
(Pseudomonas
aeruginosa)
4 / 8 GLY A 139
GLY A 138
ALA A 141
ALA A 142
None
0.63A 2ha4A-5f83A:
undetectable
2ha4A-5f83A:
19.85
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2HA4_B_ACTB601_0
(ACETYLCHOLINESTERASE)
5f83 BETA-LACTAMASE
(Pseudomonas
aeruginosa)
4 / 7 GLY A 139
GLY A 138
ALA A 141
ALA A 142
None
0.64A 2ha4B-5f83A:
undetectable
2ha4B-5f83A:
19.85
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2WA2_A_SAMA1248_0
(NON-STRUCTURAL
PROTEIN 5)
5f83 BETA-LACTAMASE
(Pseudomonas
aeruginosa)
5 / 12 GLY A 242
GLY A 227
VAL A 185
THR A 184
ILE A 241
None
0.91A 2wa2A-5f83A:
undetectable
2wa2A-5f83A:
24.65
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2WA2_B_SAMB1267_0
(NON-STRUCTURAL
PROTEIN 5)
5f83 BETA-LACTAMASE
(Pseudomonas
aeruginosa)
6 / 12 GLY A 242
GLY A 227
VAL A 185
THR A 184
ASP A 240
ILE A 241
None
1.13A 2wa2B-5f83A:
undetectable
2wa2B-5f83A:
24.65
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2ZSE_A_PAUA600_0
(PANTOTHENATE KINASE)
5f83 BETA-LACTAMASE
(Pseudomonas
aeruginosa)
4 / 7 TYR A 256
PHE A 147
ILE A 241
ASN A 239
None
1.17A 2zseA-5f83A:
undetectable
2zseA-5f83A:
21.00
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3HLW_A_CE3A301_1
(CTX-M-9
EXTENDED-SPECTRUM
BETA-LACTAMASE)
5f83 BETA-LACTAMASE
(Pseudomonas
aeruginosa)
6 / 12 LYS A  67
SER A 125
ASN A 127
THR A 211
LYS A 229
GLY A 231
IM2  A 301 ( 3.9A)
IM2  A 301 (-2.7A)
IM2  A 301 (-3.2A)
IM2  A 301 (-4.1A)
IM2  A 301 (-3.3A)
IM2  A 301 (-3.3A)
0.29A 3hlwA-5f83A:
39.3
3hlwA-5f83A:
37.27
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3HLW_B_CE3B302_1
(CTX-M-9
EXTENDED-SPECTRUM
BETA-LACTAMASE)
5f83 BETA-LACTAMASE
(Pseudomonas
aeruginosa)
6 / 12 SER A 125
ASN A 127
THR A 211
LYS A 229
THR A 230
GLY A 231
IM2  A 301 (-2.7A)
IM2  A 301 (-3.2A)
IM2  A 301 (-4.1A)
IM2  A 301 (-3.3A)
IM2  A 301 (-3.6A)
IM2  A 301 (-3.3A)
0.23A 3hlwB-5f83A:
39.3
3hlwB-5f83A:
37.27
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3HUO_A_PNNA300_0
(CTX-M-9
EXTENDED-SPECTRUM
BETA-LACTAMASE)
5f83 BETA-LACTAMASE
(Pseudomonas
aeruginosa)
5 / 12 LYS A  67
ASN A 127
LYS A 229
THR A 230
GLY A 231
IM2  A 301 ( 3.9A)
IM2  A 301 (-3.2A)
IM2  A 301 (-3.3A)
IM2  A 301 (-3.6A)
IM2  A 301 (-3.3A)
0.19A 3huoA-5f83A:
39.4
3huoA-5f83A:
37.27
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3K9F_H_LFXH0_1
(DNA TOPOISOMERASE 4
SUBUNIT A
DNA TOPOISOMERASE 4
SUBUNIT B)
5f83 BETA-LACTAMASE
(Pseudomonas
aeruginosa)
4 / 6 ARG A  87
GLY A  85
GLU A 136
GLU A  83
None
1.16A 3k9fA-5f83A:
undetectable
3k9fB-5f83A:
undetectable
3k9fD-5f83A:
undetectable
3k9fA-5f83A:
19.51
3k9fB-5f83A:
19.51
3k9fD-5f83A:
21.05
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3MZE_A_CFXA364_1
(D-ALANYL-D-ALANINE
CARBOXYPEPTIDASE
DACA)
5f83 BETA-LACTAMASE
(Pseudomonas
aeruginosa)
6 / 12 SER A  64
LYS A  67
ASN A 127
THR A 230
GLY A 231
ARG A 238
IM2  A 301 (-1.4A)
IM2  A 301 ( 3.9A)
IM2  A 301 (-3.2A)
IM2  A 301 (-3.6A)
IM2  A 301 (-3.3A)
IM2  A 301 (-3.5A)
0.93A 3mzeA-5f83A:
22.4
3mzeA-5f83A:
24.42
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3NY4_A_SMXA308_1
(BETA-LACTAMASE)
5f83 BETA-LACTAMASE
(Pseudomonas
aeruginosa)
7 / 12 SER A  64
SER A 125
THR A 211
LYS A 229
THR A 230
GLY A 231
THR A 232
IM2  A 301 (-1.4A)
IM2  A 301 (-2.7A)
IM2  A 301 (-4.1A)
IM2  A 301 (-3.3A)
IM2  A 301 (-3.6A)
IM2  A 301 (-3.3A)
IM2  A 301 (-4.0A)
0.50A 3ny4A-5f83A:
37.8
3ny4A-5f83A:
37.45
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3NY4_A_SMXA308_1
(BETA-LACTAMASE)
5f83 BETA-LACTAMASE
(Pseudomonas
aeruginosa)
6 / 12 THR A 211
LYS A 229
THR A 230
GLY A 231
THR A 232
GLY A 237
IM2  A 301 (-4.1A)
IM2  A 301 (-3.3A)
IM2  A 301 (-3.6A)
IM2  A 301 (-3.3A)
IM2  A 301 (-4.0A)
None
1.31A 3ny4A-5f83A:
37.8
3ny4A-5f83A:
37.45
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3Q07_A_WPPA300_1
(BETA-LACTAMASE)
5f83 BETA-LACTAMASE
(Pseudomonas
aeruginosa)
6 / 12 LYS A  67
SER A 125
ASN A 127
LYS A 229
GLY A 231
ASP A 166
IM2  A 301 ( 3.9A)
IM2  A 301 (-2.7A)
IM2  A 301 (-3.2A)
IM2  A 301 (-3.3A)
IM2  A 301 (-3.3A)
None
1.12A 3q07A-5f83A:
39.4
3q07A-5f83A:
37.27
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3Q07_B_WPPB400_1
(BETA-LACTAMASE)
5f83 BETA-LACTAMASE
(Pseudomonas
aeruginosa)
6 / 12 LYS A  67
SER A 125
ASN A 127
LYS A 229
GLY A 231
ASP A 166
IM2  A 301 ( 3.9A)
IM2  A 301 (-2.7A)
IM2  A 301 (-3.2A)
IM2  A 301 (-3.3A)
IM2  A 301 (-3.3A)
None
1.13A 3q07B-5f83A:
37.0
3q07B-5f83A:
37.27
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3RET_A_SALA201_1
(SALICYLATE
BIOSYNTHESIS PROTEIN
PCHB)
5f83 BETA-LACTAMASE
(Pseudomonas
aeruginosa)
5 / 10 VAL A 185
ALA A  71
VAL A 122
ILE A 202
ILE A 241
None
1.31A 3retA-5f83A:
undetectable
3retB-5f83A:
undetectable
3retA-5f83A:
19.40
3retB-5f83A:
19.40
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3SH8_A_CEDA1_1
(BETA-LACTAMASE)
5f83 BETA-LACTAMASE
(Pseudomonas
aeruginosa)
7 / 12 SER A  64
SER A 125
ASN A 127
LYS A 229
THR A 230
GLY A 231
ARG A 238
IM2  A 301 (-1.4A)
IM2  A 301 (-2.7A)
IM2  A 301 (-3.2A)
IM2  A 301 (-3.3A)
IM2  A 301 (-3.6A)
IM2  A 301 (-3.3A)
IM2  A 301 (-3.5A)
0.28A 3sh8A-5f83A:
36.7
3sh8A-5f83A:
34.31
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3SH8_B_CEDB1_1
(BETA-LACTAMASE)
5f83 BETA-LACTAMASE
(Pseudomonas
aeruginosa)
7 / 12 SER A  64
LYS A  67
SER A 125
ASN A 127
LYS A 229
GLY A 231
ARG A 238
IM2  A 301 (-1.4A)
IM2  A 301 ( 3.9A)
IM2  A 301 (-2.7A)
IM2  A 301 (-3.2A)
IM2  A 301 (-3.3A)
IM2  A 301 (-3.3A)
IM2  A 301 (-3.5A)
0.32A 3sh8B-5f83A:
36.1
3sh8B-5f83A:
34.31
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4DA6_A_GA2A301_1
(PURINE NUCLEOSIDE
PHOSPHORYLASE
DEOD-TYPE)
5f83 BETA-LACTAMASE
(Pseudomonas
aeruginosa)
5 / 9 MET A 164
GLY A 128
GLU A 163
SER A 100
ASP A 126
IM2  A 301 ( 4.6A)
None
None
None
None
1.49A 4da6A-5f83A:
undetectable
4da6A-5f83A:
19.50
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4EUZ_A_MEMA401_1
(CARBAPENEM-HYDROLIZI
NG BETA-LACTAMASE
SFC-1)
5f83 BETA-LACTAMASE
(Pseudomonas
aeruginosa)
8 / 12 LYS A  67
SER A 125
ASN A 127
THR A 211
LYS A 229
THR A 230
GLY A 231
THR A 232
IM2  A 301 ( 3.9A)
IM2  A 301 (-2.7A)
IM2  A 301 (-3.2A)
IM2  A 301 (-4.1A)
IM2  A 301 (-3.3A)
IM2  A 301 (-3.6A)
IM2  A 301 (-3.3A)
IM2  A 301 (-4.0A)
0.44A 4euzA-5f83A:
39.4
4euzA-5f83A:
40.14
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4FH2_A_0RNA303_1
(BETA-LACTAMASE SHV-1)
5f83 BETA-LACTAMASE
(Pseudomonas
aeruginosa)
6 / 10 SER A 125
ASN A 127
LYS A 229
THR A 230
GLY A 231
ARG A 238
IM2  A 301 (-2.7A)
IM2  A 301 (-3.2A)
IM2  A 301 (-3.3A)
IM2  A 301 (-3.6A)
IM2  A 301 (-3.3A)
IM2  A 301 (-3.5A)
0.48A 4fh2A-5f83A:
37.5
4fh2A-5f83A:
36.00
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4KCN_A_MTLA804_0
(NITRIC OXIDE
SYNTHASE, BRAIN)
5f83 BETA-LACTAMASE
(Pseudomonas
aeruginosa)
4 / 6 ARG A 156
ASP A 171
ASP A 158
ARG A 173
None
1.40A 4kcnA-5f83A:
undetectable
4kcnA-5f83A:
22.46
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4KCN_B_MTLB805_0
(NITRIC OXIDE
SYNTHASE, BRAIN)
5f83 BETA-LACTAMASE
(Pseudomonas
aeruginosa)
4 / 6 ARG A 156
ASP A 171
ASP A 158
ARG A 173
None
1.38A 4kcnB-5f83A:
undetectable
4kcnB-5f83A:
22.46
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4MM5_A_SREA603_1
(TRANSPORTER)
5f83 BETA-LACTAMASE
(Pseudomonas
aeruginosa)
5 / 9 PRO A  69
ALA A  71
GLY A  63
PHE A  66
SER A 125
None
None
IM2  A 301 ( 3.9A)
None
IM2  A 301 (-2.7A)
1.32A 4mm5A-5f83A:
undetectable
4mm5A-5f83A:
20.15
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4MMB_A_SREA603_1
(TRANSPORTER)
5f83 BETA-LACTAMASE
(Pseudomonas
aeruginosa)
5 / 9 PRO A  69
ALA A  71
GLY A  63
PHE A  66
SER A 125
None
None
IM2  A 301 ( 3.9A)
None
IM2  A 301 (-2.7A)
1.29A 4mmbA-5f83A:
0.4
4mmbA-5f83A:
20.08
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4N9K_A_CEDA301_1
(BETA-LACTAMASE)
5f83 BETA-LACTAMASE
(Pseudomonas
aeruginosa)
7 / 12 SER A  64
SER A 125
ASN A 127
LYS A 229
THR A 230
GLY A 231
ARG A 238
IM2  A 301 (-1.4A)
IM2  A 301 (-2.7A)
IM2  A 301 (-3.2A)
IM2  A 301 (-3.3A)
IM2  A 301 (-3.6A)
IM2  A 301 (-3.3A)
IM2  A 301 (-3.5A)
0.24A 4n9kA-5f83A:
38.4
4n9kA-5f83A:
34.18
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4N9K_B_CEDB301_1
(BETA-LACTAMASE)
5f83 BETA-LACTAMASE
(Pseudomonas
aeruginosa)
7 / 12 SER A  64
SER A 125
ASN A 127
LYS A 229
THR A 230
GLY A 231
ARG A 238
IM2  A 301 (-1.4A)
IM2  A 301 (-2.7A)
IM2  A 301 (-3.2A)
IM2  A 301 (-3.3A)
IM2  A 301 (-3.6A)
IM2  A 301 (-3.3A)
IM2  A 301 (-3.5A)
0.26A 4n9kB-5f83A:
38.3
4n9kB-5f83A:
34.18
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4PM5_A_CE3A301_1
(BETA-LACTAMASE
CTX-M-14)
5f83 BETA-LACTAMASE
(Pseudomonas
aeruginosa)
5 / 12 ASN A 127
THR A 211
LYS A 229
THR A 230
GLY A 231
IM2  A 301 (-3.2A)
IM2  A 301 (-4.1A)
IM2  A 301 (-3.3A)
IM2  A 301 (-3.6A)
IM2  A 301 (-3.3A)
0.21A 4pm5A-5f83A:
39.4
4pm5A-5f83A:
37.64
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4PM7_A_CE3A301_1
(BETA-LACTAMASE
CTX-M-14)
5f83 BETA-LACTAMASE
(Pseudomonas
aeruginosa)
5 / 12 LYS A  67
ASN A 127
THR A 211
LYS A 229
GLY A 231
IM2  A 301 ( 3.9A)
IM2  A 301 (-3.2A)
IM2  A 301 (-4.1A)
IM2  A 301 (-3.3A)
IM2  A 301 (-3.3A)
0.30A 4pm7A-5f83A:
39.4
4pm7A-5f83A:
37.64
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4PM7_A_CE3A301_1
(BETA-LACTAMASE
CTX-M-14)
5f83 BETA-LACTAMASE
(Pseudomonas
aeruginosa)
5 / 12 LYS A  67
SER A 125
ASN A 127
LYS A 229
GLY A 231
IM2  A 301 ( 3.9A)
IM2  A 301 (-2.7A)
IM2  A 301 (-3.2A)
IM2  A 301 (-3.3A)
IM2  A 301 (-3.3A)
0.74A 4pm7A-5f83A:
39.4
4pm7A-5f83A:
37.64
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4PM9_A_CE3A301_1
(BETA-LACTAMASE
CTX-M-14)
5f83 BETA-LACTAMASE
(Pseudomonas
aeruginosa)
5 / 12 ASN A 127
THR A 211
LYS A 229
THR A 230
GLY A 231
IM2  A 301 (-3.2A)
IM2  A 301 (-4.1A)
IM2  A 301 (-3.3A)
IM2  A 301 (-3.6A)
IM2  A 301 (-3.3A)
0.22A 4pm9A-5f83A:
39.5
4pm9A-5f83A:
38.01
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4R20_B_AERB602_1
(CYTOCHROME P450
FAMILY 17
POLYPEPTIDE 2)
5f83 BETA-LACTAMASE
(Pseudomonas
aeruginosa)
5 / 9 ALA A  42
VAL A 188
GLY A 242
THR A  65
SER A 155
None
1.12A 4r20B-5f83A:
undetectable
4r20B-5f83A:
20.67
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4RP8_C_ASCC501_0
(ASCORBATE-SPECIFIC
PERMEASE IIC
COMPONENT ULAA)
5f83 BETA-LACTAMASE
(Pseudomonas
aeruginosa)
6 / 12 LEU A 194
ILE A 150
ILE A 202
ALA A  71
PHE A  68
MET A 181
None
1.34A 4rp8C-5f83A:
undetectable
4rp8C-5f83A:
20.81
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4YB6_A_HISA302_0
(ATP
PHOSPHORIBOSYLTRANSF
ERASE)
5f83 BETA-LACTAMASE
(Pseudomonas
aeruginosa)
5 / 10 GLY A  40
VAL A  41
VAL A 255
LEU A  31
LEU A 216
None
1.10A 4yb6A-5f83A:
undetectable
4yb6E-5f83A:
undetectable
4yb6A-5f83A:
20.25
4yb6E-5f83A:
20.25
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4YB6_B_HISB302_0
(ATP
PHOSPHORIBOSYLTRANSF
ERASE)
5f83 BETA-LACTAMASE
(Pseudomonas
aeruginosa)
5 / 10 GLY A  40
VAL A  41
VAL A 255
LEU A  31
LEU A 216
None
1.10A 4yb6B-5f83A:
undetectable
4yb6C-5f83A:
undetectable
4yb6B-5f83A:
20.25
4yb6C-5f83A:
20.25
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4YB6_C_HISC302_0
(ATP
PHOSPHORIBOSYLTRANSF
ERASE)
5f83 BETA-LACTAMASE
(Pseudomonas
aeruginosa)
5 / 10 GLY A  40
VAL A  41
VAL A 255
LEU A  31
LEU A 216
None
1.12A 4yb6C-5f83A:
undetectable
4yb6F-5f83A:
undetectable
4yb6C-5f83A:
20.25
4yb6F-5f83A:
20.25
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4YB6_D_HISD302_0
(ATP
PHOSPHORIBOSYLTRANSF
ERASE)
5f83 BETA-LACTAMASE
(Pseudomonas
aeruginosa)
5 / 10 LEU A  31
LEU A 216
GLY A  40
VAL A  41
VAL A 255
None
1.14A 4yb6A-5f83A:
undetectable
4yb6D-5f83A:
undetectable
4yb6A-5f83A:
20.25
4yb6D-5f83A:
20.25
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4YB6_E_HISE302_0
(ATP
PHOSPHORIBOSYLTRANSF
ERASE)
5f83 BETA-LACTAMASE
(Pseudomonas
aeruginosa)
5 / 10 LEU A  31
LEU A 216
GLY A  40
VAL A  41
VAL A 255
None
1.14A 4yb6D-5f83A:
undetectable
4yb6E-5f83A:
undetectable
4yb6D-5f83A:
20.25
4yb6E-5f83A:
20.25
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4YB6_F_HISF302_0
(ATP
PHOSPHORIBOSYLTRANSF
ERASE)
5f83 BETA-LACTAMASE
(Pseudomonas
aeruginosa)
5 / 10 LEU A  31
LEU A 216
GLY A  40
VAL A  41
VAL A 255
None
1.10A 4yb6B-5f83A:
undetectable
4yb6F-5f83A:
undetectable
4yb6B-5f83A:
20.25
4yb6F-5f83A:
20.25
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5G5G_A_ACTA1231_0
(PUTATIVE XANTHINE
DEHYDROGENASE YAGR
MOLYBDENUM-BINDING
SU SUBUNIT
PUTATIVE XANTHINE
DEHYDROGENASE YAGT
IRON-SULFUR-BINDING
SUBUNIT)
5f83 BETA-LACTAMASE
(Pseudomonas
aeruginosa)
3 / 3 ARG A 159
THR A 168
ASP A 171
None
0.84A 5g5gA-5f83A:
undetectable
5g5gB-5f83A:
undetectable
5g5gA-5f83A:
21.68
5g5gB-5f83A:
23.91
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5GHY_A_CEDA301_1
(BETA-LACTAMASE)
5f83 BETA-LACTAMASE
(Pseudomonas
aeruginosa)
6 / 12 SER A  64
SER A 125
ASN A 127
LYS A 229
GLY A 231
ARG A 238
IM2  A 301 (-1.4A)
IM2  A 301 (-2.7A)
IM2  A 301 (-3.2A)
IM2  A 301 (-3.3A)
IM2  A 301 (-3.3A)
IM2  A 301 (-3.5A)
0.29A 5ghyA-5f83A:
37.9
5ghyA-5f83A:
34.18
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5GHY_B_CEDB301_1
(BETA-LACTAMASE)
5f83 BETA-LACTAMASE
(Pseudomonas
aeruginosa)
6 / 12 SER A  64
SER A 125
ASN A 127
LYS A 229
GLY A 231
ARG A 238
IM2  A 301 (-1.4A)
IM2  A 301 (-2.7A)
IM2  A 301 (-3.2A)
IM2  A 301 (-3.3A)
IM2  A 301 (-3.3A)
IM2  A 301 (-3.5A)
0.27A 5ghyB-5f83A:
38.0
5ghyB-5f83A:
34.18
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5GHZ_A_CEDA301_1
(BETA-LACTAMASE)
5f83 BETA-LACTAMASE
(Pseudomonas
aeruginosa)
7 / 11 SER A  64
SER A 125
ASN A 127
LYS A 229
THR A 230
GLY A 231
ARG A 238
IM2  A 301 (-1.4A)
IM2  A 301 (-2.7A)
IM2  A 301 (-3.2A)
IM2  A 301 (-3.3A)
IM2  A 301 (-3.6A)
IM2  A 301 (-3.3A)
IM2  A 301 (-3.5A)
0.26A 5ghzA-5f83A:
38.0
5ghzA-5f83A:
34.18
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5GHZ_B_CEDB301_1
(BETA-LACTAMASE)
5f83 BETA-LACTAMASE
(Pseudomonas
aeruginosa)
7 / 10 SER A  64
SER A 125
ASN A 127
LYS A 229
THR A 230
GLY A 231
ARG A 238
IM2  A 301 (-1.4A)
IM2  A 301 (-2.7A)
IM2  A 301 (-3.2A)
IM2  A 301 (-3.3A)
IM2  A 301 (-3.6A)
IM2  A 301 (-3.3A)
IM2  A 301 (-3.5A)
0.27A 5ghzB-5f83A:
38.0
5ghzB-5f83A:
34.18
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5OJ0_A_9WTA801_0
(PENICILLIN-BINDING
PROTEIN 2X)
5f83 BETA-LACTAMASE
(Pseudomonas
aeruginosa)
5 / 12 TRP A  99
SER A 125
THR A 211
GLY A 231
THR A 232
IM2  A 301 ( 4.0A)
IM2  A 301 (-2.7A)
IM2  A 301 (-4.1A)
IM2  A 301 (-3.3A)
IM2  A 301 (-4.0A)
1.23A 5oj0A-5f83A:
6.9
5oj0A-5f83A:
18.44
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5WM2_A_ACTA605_0
(SALICYLATE-AMP
LIGASE)
5f83 BETA-LACTAMASE
(Pseudomonas
aeruginosa)
3 / 3 THR A 211
THR A 230
ARG A 238
IM2  A 301 (-4.1A)
IM2  A 301 (-3.6A)
IM2  A 301 (-3.5A)
1.00A 5wm2A-5f83A:
undetectable
5wm2A-5f83A:
20.14
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6B5Y_B_9F2B400_1
(BETA-LACTAMASE)
5f83 BETA-LACTAMASE
(Pseudomonas
aeruginosa)
7 / 12 SER A  64
SER A 125
THR A 211
LYS A 229
THR A 230
GLY A 231
THR A 232
IM2  A 301 (-1.4A)
IM2  A 301 (-2.7A)
IM2  A 301 (-4.1A)
IM2  A 301 (-3.3A)
IM2  A 301 (-3.6A)
IM2  A 301 (-3.3A)
IM2  A 301 (-4.0A)
0.39A 6b5yB-5f83A:
38.3
6b5yB-5f83A:
15.99
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6B5Y_D_9F2D400_1
(BETA-LACTAMASE)
5f83 BETA-LACTAMASE
(Pseudomonas
aeruginosa)
7 / 12 SER A  64
SER A 125
THR A 211
LYS A 229
THR A 230
GLY A 231
THR A 232
IM2  A 301 (-1.4A)
IM2  A 301 (-2.7A)
IM2  A 301 (-4.1A)
IM2  A 301 (-3.3A)
IM2  A 301 (-3.6A)
IM2  A 301 (-3.3A)
IM2  A 301 (-4.0A)
0.46A 6b5yD-5f83A:
38.2
6b5yD-5f83A:
15.99
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6B5Y_D_9F2D400_1
(BETA-LACTAMASE)
5f83 BETA-LACTAMASE
(Pseudomonas
aeruginosa)
6 / 12 THR A 211
LYS A 229
THR A 230
GLY A 231
THR A 232
GLY A 237
IM2  A 301 (-4.1A)
IM2  A 301 (-3.3A)
IM2  A 301 (-3.6A)
IM2  A 301 (-3.3A)
IM2  A 301 (-4.0A)
None
1.33A 6b5yD-5f83A:
38.2
6b5yD-5f83A:
15.99
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6B68_B_9F2B301_1
(BETA-LACTAMASE)
5f83 BETA-LACTAMASE
(Pseudomonas
aeruginosa)
7 / 12 SER A  64
SER A 125
THR A 211
LYS A 229
THR A 230
GLY A 231
THR A 232
IM2  A 301 (-1.4A)
IM2  A 301 (-2.7A)
IM2  A 301 (-4.1A)
IM2  A 301 (-3.3A)
IM2  A 301 (-3.6A)
IM2  A 301 (-3.3A)
IM2  A 301 (-4.0A)
0.33A 6b68B-5f83A:
38.5
6b68B-5f83A:
15.99
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6B68_B_9F2B301_1
(BETA-LACTAMASE)
5f83 BETA-LACTAMASE
(Pseudomonas
aeruginosa)
6 / 12 THR A 211
LYS A 229
THR A 230
GLY A 231
THR A 232
GLY A 237
IM2  A 301 (-4.1A)
IM2  A 301 (-3.3A)
IM2  A 301 (-3.6A)
IM2  A 301 (-3.3A)
IM2  A 301 (-4.0A)
None
1.40A 6b68B-5f83A:
38.5
6b68B-5f83A:
15.99
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6B68_D_9F2D400_1
(BETA-LACTAMASE)
5f83 BETA-LACTAMASE
(Pseudomonas
aeruginosa)
6 / 12 SER A  64
SER A 125
THR A 211
LYS A 229
GLY A 231
THR A 232
IM2  A 301 (-1.4A)
IM2  A 301 (-2.7A)
IM2  A 301 (-4.1A)
IM2  A 301 (-3.3A)
IM2  A 301 (-3.3A)
IM2  A 301 (-4.0A)
0.40A 6b68D-5f83A:
38.3
6b68D-5f83A:
15.99
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6B69_B_9F2B301_1
(BETA-LACTAMASE)
5f83 BETA-LACTAMASE
(Pseudomonas
aeruginosa)
8 / 12 SER A  64
SER A 125
PRO A 162
THR A 211
LYS A 229
THR A 230
GLY A 231
THR A 232
IM2  A 301 (-1.4A)
IM2  A 301 (-2.7A)
None
IM2  A 301 (-4.1A)
IM2  A 301 (-3.3A)
IM2  A 301 (-3.6A)
IM2  A 301 (-3.3A)
IM2  A 301 (-4.0A)
0.47A 6b69A-5f83A:
38.4
6b69B-5f83A:
38.4
6b69A-5f83A:
15.99
6b69B-5f83A:
15.99
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6B69_B_9F2B301_1
(BETA-LACTAMASE)
5f83 BETA-LACTAMASE
(Pseudomonas
aeruginosa)
6 / 12 THR A 211
LYS A 229
THR A 230
GLY A 231
THR A 232
GLY A 237
IM2  A 301 (-4.1A)
IM2  A 301 (-3.3A)
IM2  A 301 (-3.6A)
IM2  A 301 (-3.3A)
IM2  A 301 (-4.0A)
None
1.40A 6b69A-5f83A:
38.4
6b69B-5f83A:
38.4
6b69A-5f83A:
15.99
6b69B-5f83A:
15.99
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6B69_D_9F2D301_1
(BETA-LACTAMASE)
5f83 BETA-LACTAMASE
(Pseudomonas
aeruginosa)
7 / 12 SER A  64
SER A 125
THR A 211
LYS A 229
THR A 230
GLY A 231
THR A 232
IM2  A 301 (-1.4A)
IM2  A 301 (-2.7A)
IM2  A 301 (-4.1A)
IM2  A 301 (-3.3A)
IM2  A 301 (-3.6A)
IM2  A 301 (-3.3A)
IM2  A 301 (-4.0A)
0.33A 6b69D-5f83A:
38.3
6b69D-5f83A:
15.99
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6B6A_B_9F2B301_1
(BETA-LACTAMASE)
5f83 BETA-LACTAMASE
(Pseudomonas
aeruginosa)
7 / 12 SER A  64
SER A 125
THR A 211
LYS A 229
THR A 230
GLY A 231
THR A 232
IM2  A 301 (-1.4A)
IM2  A 301 (-2.7A)
IM2  A 301 (-4.1A)
IM2  A 301 (-3.3A)
IM2  A 301 (-3.6A)
IM2  A 301 (-3.3A)
IM2  A 301 (-4.0A)
0.37A 6b6aB-5f83A:
38.4
6b6aB-5f83A:
15.99
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6B6A_D_9F2D301_1
(BETA-LACTAMASE)
5f83 BETA-LACTAMASE
(Pseudomonas
aeruginosa)
6 / 12 SER A  64
SER A 125
LYS A 229
THR A 230
GLY A 231
THR A 232
IM2  A 301 (-1.4A)
IM2  A 301 (-2.7A)
IM2  A 301 (-3.3A)
IM2  A 301 (-3.6A)
IM2  A 301 (-3.3A)
IM2  A 301 (-4.0A)
0.28A 6b6aD-5f83A:
38.3
6b6aD-5f83A:
15.99
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6B6C_A_9F2A301_1
(BETA-LACTAMASE)
5f83 BETA-LACTAMASE
(Pseudomonas
aeruginosa)
7 / 12 SER A  64
SER A 125
PRO A 162
LYS A 229
THR A 230
GLY A 231
THR A 232
IM2  A 301 (-1.4A)
IM2  A 301 (-2.7A)
None
IM2  A 301 (-3.3A)
IM2  A 301 (-3.6A)
IM2  A 301 (-3.3A)
IM2  A 301 (-4.0A)
0.63A 6b6cA-5f83A:
38.3
6b6cA-5f83A:
15.99
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6B6D_A_9F2A302_1
(BETA-LACTAMASE)
5f83 BETA-LACTAMASE
(Pseudomonas
aeruginosa)
7 / 12 SER A  64
SER A 125
THR A 211
LYS A 229
THR A 230
GLY A 231
THR A 232
IM2  A 301 (-1.4A)
IM2  A 301 (-2.7A)
IM2  A 301 (-4.1A)
IM2  A 301 (-3.3A)
IM2  A 301 (-3.6A)
IM2  A 301 (-3.3A)
IM2  A 301 (-4.0A)
0.59A 6b6dA-5f83A:
38.0
6b6dA-5f83A:
15.99
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6B6E_A_9F2A302_1
(BETA-LACTAMASE)
5f83 BETA-LACTAMASE
(Pseudomonas
aeruginosa)
7 / 12 SER A  64
SER A 125
THR A 211
LYS A 229
THR A 230
GLY A 231
THR A 232
IM2  A 301 (-1.4A)
IM2  A 301 (-2.7A)
IM2  A 301 (-4.1A)
IM2  A 301 (-3.3A)
IM2  A 301 (-3.6A)
IM2  A 301 (-3.3A)
IM2  A 301 (-4.0A)
0.34A 6b6eA-5f83A:
38.2
6b6eA-5f83A:
15.99
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6B6E_A_9F2A302_1
(BETA-LACTAMASE)
5f83 BETA-LACTAMASE
(Pseudomonas
aeruginosa)
6 / 12 THR A 211
LYS A 229
THR A 230
GLY A 231
THR A 232
GLY A 237
IM2  A 301 (-4.1A)
IM2  A 301 (-3.3A)
IM2  A 301 (-3.6A)
IM2  A 301 (-3.3A)
IM2  A 301 (-4.0A)
None
1.39A 6b6eA-5f83A:
38.2
6b6eA-5f83A:
15.99
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6B6F_A_9F2A301_1
(BETA-LACTAMASE)
5f83 BETA-LACTAMASE
(Pseudomonas
aeruginosa)
7 / 12 SER A  64
SER A 125
PRO A 162
LYS A 229
THR A 230
GLY A 231
THR A 232
IM2  A 301 (-1.4A)
IM2  A 301 (-2.7A)
None
IM2  A 301 (-3.3A)
IM2  A 301 (-3.6A)
IM2  A 301 (-3.3A)
IM2  A 301 (-4.0A)
0.72A 6b6fA-5f83A:
37.9
6b6fA-5f83A:
15.99
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6C79_A_CE3A301_1
(BETA-LACTAMASE
TOHO-1)
5f83 BETA-LACTAMASE
(Pseudomonas
aeruginosa)
5 / 12 SER A 125
ASN A 127
THR A 211
LYS A 229
GLY A 231
IM2  A 301 (-2.7A)
IM2  A 301 (-3.2A)
IM2  A 301 (-4.1A)
IM2  A 301 (-3.3A)
IM2  A 301 (-3.3A)
0.13A 6c79A-5f83A:
39.0
6c79A-5f83A:
14.79